We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
If device reprocessors had more legal responsibility for adverse events linked to reused single-use devices (SUDs), the original
devicemakers would not have to worry so much about liability when problems arise with the reused devices, an expert says.
The NIH will award almost $700 million in research grants to 12 academic health centers between Oct. 1, 2006, and June 30, 2011, about $100 million of that in the nine-month period ending June 30, 2007.
The NIH will award almost $700 million in research grants to 12 academic health centers between Oct. 1, 2006, and June 30, 2011, roughly $100 million of that in the nine-month period ending June 30, 2007.
Pacemaker and implantable cardioverter-defibrillator (ICD) manufacturers could possibly make their products safe for patients who undergo magnetic resonance imaging (MRI) scans, a researcher says.
Delayed drug approvals have caused Altana Pharma to dismantle its marketing and sales organization in Florham Park, N.J. by the end of the year, the company announced Oct. 3.
The overall cholesterol drug market is growing faster than anticipated, with the introduction of generic Zocor not hurting the competition, according to one analyst.